Clinical trial
Bifidobacterium Lactulose Optimization in Oncology and Microbiome (BLOOM)
NCT07354100 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bifidobacterium Lactulose Optimization in Oncology and Microbiome (BLOOM)
- Lead sponsor
- University of Chicago
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- December 15, 2026
- Completion date
- April 13, 2029
- Enrollment
- 55 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer